| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| EXELIXIS, INC. | Director | Common Stock | 20,590 | $744,740 | $36.17 | 29 May 2025 | Direct |
| Stoke Therapeutics, Inc. | Director | Director Stock Option (Right to Buy) | 29,747 | 03 Jun 2025 | Direct | ||
| EXELIXIS, INC. | Director | Option (right to buy) | 20,030 | 31 May 2024 | Direct | ||
| EXELIXIS, INC. | Director | Option (right to buy) | 0 | 28 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| STOK | Stoke Therapeutics, Inc. | 03 Jun 2025 | 1 | $0 | 4 | Director | 04 Jun 2025, 20:38 |
| EXEL | EXELIXIS, INC. | 29 May 2025 | 1 | $0 | 4 | Director | 30 May 2025, 19:12 |
| EXEL | EXELIXIS, INC. | 27 Feb 2025 | 8 | -$1,322,523 | 4 | Director | 28 Feb 2025, 20:35 |
| EXEL | EXELIXIS, INC. | 13 Aug 2024 | 1 | $0 | 4 | Director | 15 Aug 2024, 20:18 |
| STOK | Stoke Therapeutics, Inc. | 05 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 16:27 |
| EXEL | EXELIXIS, INC. | 31 May 2024 | 2 | $0 | 4 | Director | 04 Jun 2024, 20:19 |
| EXEL | EXELIXIS, INC. | 21 May 2024 | 1 | -$576,154 | 4 | Director | 23 May 2024, 18:55 |
| STOK | Stoke Therapeutics, Inc. | 13 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 18:26 |
| EXEL | EXELIXIS, INC. | 01 Jun 2023 | 1 | $0 | 4 | Director | 02 Jun 2023, 21:10 |
| STOK | Stoke Therapeutics, Inc. | 07 Jun 2022 | 1 | $0 | 4 | Director | 08 Jun 2022, 17:00 |
| EXEL | EXELIXIS, INC. | 26 May 2022 | 1 | $0 | 4 | Director | 27 May 2022, 21:12 |
| STOK | Stoke Therapeutics, Inc. | 08 Jun 2021 | 1 | $0 | 4 | Director | 25 Jun 2021, 17:02 |
| EXEL | EXELIXIS, INC. | 27 May 2021 | 1 | $0 | 4 | Director | 28 May 2021, 20:08 |